Sana Biotechnology, Inc. (NASDAQ:SANA) Financings

Sana Biotechnology, Inc.

Financings

RaiseDate
Strategic investment of equity
Announced: strategic investment
Buyers: Mayo Clinic
Apr 13, 2026
At-the-market programme of common stock
Tranche closed: US$47.4M raised
Mar 3, 2026
Public offering of common stock
Closed: US$86.3M raised · US$3.35 a share · Morgan Stanley +3
Dealers: Morgan Stanley (co-lead), Goldman Sachs & Co. LLC (co-lead), BofA Securities (co-lead), TD Cowen (co-lead)
Aug 20, 2025

Read by 6ix AI from the company's releases